Cosmesis and Body Image in Patients Undergoing Single-port Versus Conventional Laparoscopic Cholecystectomy: A Multicenter Double-blinded Randomized Controlled Trial (SPOCC-trial)
Overview
Authors
Affiliations
Objective: To evaluate cosmesis, body image, pain, and quality of life (QoL) after single-port laparoscopic cholecystectomy (SPLC) versus conventional 4-port laparoscopic cholecystectomy (4PLC).
Background: The impact of SPLC on improving cosmesis, body image, pain, and QoL has not been evaluated in double-blinded randomized controlled trials (RCT). This approach therefore remains controversial.
Methods: Between October 2011 and February 2014, 110 patients from 2 centers were randomly assigned to SPLC (n = 55) or 4PLC (n = 55). Primary endpoints were a validated cosmesis (3-24 points) and body image (5-20 points) score after 3 and 12 months. Secondary endpoints included operative duration, postoperative pain, complications, QoL, and length of hospital stay. Patients, physicians, and nurses were blinded until the seventh postoperative day.
Results: Demographics were equally distributed between both groups (mean age: 46 years, SD: 14, 62 females, 34 males). The SPLC-group showed superior mean cosmesis and body image compared with the 4PLC-group at 12-weeks (21 vs 16, P < 0.001 and 5 vs 6, P = 0.013, respectively) and at 1-year (24 vs 16, P < 0.001 and 5 vs 6, P < 0.017, respectively). Operation duration was longer in the SPLC-group (mean 101 vs 90 minutes, p = 0.031). Although postoperative pain was less in the SPLC-group (mean VAS 1 vs 2, p = 0.005), there were no differences in complications, and length of hospital-stay.
Conclusions: This is the first multicenter double-blinded RCT reporting superior short- and long-term cosmetic and body image, postoperative pain, and QoL in SPLC compared with 4PLC. Although cost-effectiveness is still a subject of ongoing debate, SPLC should be offered to patients undergoing surgery for benign gallbladder disease.
Rudiman R, Hanafi R, Wijaya A F1000Res. 2025; 11:754.
PMID: 39931659 PMC: 11809676. DOI: 10.12688/f1000research.122102.1.
Antier A, Challine A, Collard M, OConnell L, Debove C, Chafai N Tech Coloproctol. 2025; 29(1):59.
PMID: 39903360 DOI: 10.1007/s10151-024-03067-2.
Yao Y, Ding J, Ju H, Yang L, Liu Y, Liang Y World J Surg Oncol. 2025; 23(1):22.
PMID: 39856731 PMC: 11762907. DOI: 10.1186/s12957-024-03630-z.
Rho S, Choi M, Kim S, Hong S, Goh B, Nagakawa Y Ann Surg Treat Res. 2024; 107(6):336-345.
PMID: 39669386 PMC: 11634393. DOI: 10.4174/astr.2024.107.6.336.
Houqiong J, Yuli Y, Fujia G, Gengmei G, Yaxiong L, Yahang L BMC Surg. 2024; 24(1):295.
PMID: 39385219 PMC: 11463158. DOI: 10.1186/s12893-024-02597-8.